Evidence map›Paper›PMID 42698095›Full record

Trial reportBMC oral health2026

How does smoking affect the clinical performance of a universal adhesive in non-carious cervical lesions? -An 18-month randomized clinical trial.

Gulnaz Aydemir, Jale Gorucu, A Ruya Yazici

Registry-linked trialAbstract readRandomized Controlled TrialEquivalence Trial
In one paragraph

Trial report in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04807465 (How Does Smoking Effect the Clinical Performance of a Universal Adhesive Used With Different Application Modes in Non Carious Cervical Lesions?), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04807465 naactive not recruitingnot on this map

How Does Smoking Effect the Clinical Performance of a Universal Adhesive Used With Different Application Modes in Non Carious Cervical Lesions?

TypeinterventionalSponsorHacettepe UniversityRan2018 to 2028Enrolled47ConditionsHealthy ParticipantArmsG-Premio Bond in etch&rinse mode, G-Premio Bond in selective-etch mode, G-Premio Bond in self-etch mode
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gulnaz AydemirDepartment of Restorative Dentistry, School of Dentistry, Hacettepe University, Ankara, 06230, Türkiye.ORCID 0000-0001-6999-9391
Jale GorucuDepartment of Restorative Dentistry, School of Dentistry, Lokman Hekim University, Ankara, 06510, Türkiye. jale.gorucu@lokmanhekim.edu.tr.ORCID 0000-0001-7138-5911
A Ruya YaziciDepartment of Restorative Dentistry, School of Dentistry, Hacettepe University, Ankara, 06230, Türkiye.ORCID 0000-0001-7065-1421

Funding

Hacettepe University Scientific Research Projects Coordination Project ID: THD-2018-16662
6 · The paper itself

Abstract

backgroundSmoking has a great impact on oral health status of the patients. As universal adhesives have become a routine dental adhesive choice, understanding the potential impact of smoking on their clinical performance is crucial. This study aimed to determine the 18-month clinical performance of a universal adhesive used with different application modes in non-carious cervical lesions(NCCLs) of smokers and non-smokers.

methodsThis double-blind, randomized, split-mouth superiority clinical trial included 47 participants(24 non-smokers and 23 smokers) presenting with at least three NCCLs. A total of 228 NCCLs were categorized in line with the smoking status of the participants and universal adhesive(G-Premio BOND) application modes (Etch&Rinse[ER], Selective-Etch[SLE] or Self-Etch[SE]). Randomization was performed at the lesion level, such that within each participant, each non-carious cervical lesion was randomly assigned to one of the three adhesive application modes. Restorations were evaluated at baseline, 6, 12 and 18-months using modified USPHS criteria and patient-reported hypersensitivity was assessed using a 0-10 visual analog scale(VAS) by two calibrated examiners blinded to group allocation. The primary outcome was retention. Secondary outcomes included marginal adaptation, marginal discoloration, color match, postoperative sensitivity and patient-reported postoperative hypersensitivity(VAS). Data were analyzed using Cochran's Q, chi-square, Mann-Whitney-U and Kaplan-Meier tests(p < 0.05).

resultsAmong the non-smokers, one restoration from the SE and one from the ER group were lost, creating no significant difference regarding retention(p > 0.05). At 18-months, no difference was detected among the application modes within each group for all USPHS criteria(p > 0.05). Kaplan-Meier survival analysis revealed no significant difference in 18-month retention between smokers and non-smokers (p = 0.59). Overall restoration success at 18 months was 100% in smokers and 99.1% in non-smokers (ER 97.5%, SLE 100%, SE 97.5%) Statistically significant differences between smokers and non-smokers were detected only for marginal discoloration at 6 months in the ER group and at 12 and 18 months in the SE group(p < 0.05). Both marginal discoloration and adaptation exhibited significant changes over time in both groups(p < 0.05). VAS scores for postoperative sensitivity were significantly higher in smokers than in non-smokers at all follow-ups(p < 0.05), except for the SE group(p > 0.05).

conclusionThe 18-month clinical performance of restorations was found to be similar regardless of the universal adhesive application mode. Smoking status primarily influenced marginal discoloration and patient-reported postoperative hypersensitivity. CLINICAL

trial registrationThe study was registered with clinicaltrials.gov retrospectively registered (protocol number NCT04807465) on 03.13.2021.

Indexed as

Dental CementsDental Restoration, PermanentSmokingTooth CervixTooth WearAdultDentin-Bonding AgentsDentin SensitivityDouble-Blind MethodFemaleHumansMaleMiddle AgedDental CementsDentin-Bonding AgentsDental adhesivesNon-smokerRandomized clinical trialSmoker

Identifiers

PMID42698095
PMCPMC13543537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.